Headlines

MicroStrategy Stock Was 10.33% Up Today

(VIANEWS) – The NASDAQ ended the session with MicroStrategy (MSTR) rising 10.33% to $961.87 on Wednesday while NASDAQ dropped 0.55% to $15,947.74. MicroStrategy’s last close was $871.80, 8.06% above its 52-week high of $806.78. About MicroStrategy MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa,…

Read More

MicroStrategy Soars 14% Ahead Of Market: Investors Bet On Bitcoin Strategy

(VIANEWS) – MicroStrategy (NASDAQ: MSTR) saw its shares skyrocket on Wednesday, rising 14.93% by 12:23 EST to EUR1,002.00 after two consecutive sessions of gains. At present, however, the NASDAQ index is trading down by 0.28% at EUR15,991.00; suggesting an overall downward trend. MicroStrategy’s last closing price was EUR871.80, an increase of 8.056% since its 52-week…

Read More

Aspen Group Stock Plummets 19% In 5 Sessions: What’s Causing The Decline?

(VIANEWS) – Aspen Group (NASDAQ: ASPU) experienced an astounding 19.23% drop over five trading sessions, from EUR0.26 to EUR0.21, from 08:23 EST on Wednesday through to yesterday evening. Despite an overall upward trend on NASDAQ which rose 0.37% at EUR16,035.30; Aspen Group did not reflect this positive momentum – its last close was EUR0.21, 19.23%…

Read More

Inovio Pharmaceuticals Stock Was 10.05% Up Today

(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals (INO) jumping 10.05% to $8.98 on Tuesday while NASDAQ rose 0.37% to $16,035.30. Inovio Pharmaceuticals’s last close was $8.16, 49.63% below its 52-week high of $16.20. About Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines…

Read More

BeiGene Stock Impressive Jump On Tuesday, Outperforms Market

(VIANEWS) – The NASDAQ ended the session with BeiGene (BGNE) rising 11.31% to $178.38 on Tuesday while NASDAQ rose 0.37% to $16,035.30. BeiGene’s last close was $160.26, 41.19% under its 52-week high of $272.49. About BeiGene BeiGene, Ltd., a biotechnology company, develops and commercializes oncology medicines worldwide. Its products include BRUKINSA to treat various blood…

Read More